Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contingency Management for PrEP Adherence and/or Methamphetamine UseDisorder Among MSM and TW in Los Angeles: A Pilot Feasibility Study

NCT04563962 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT04563962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04563962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contingency Management for PrEP Adherence and/or Methamphetamine UseDisorder Among MSM and TW in Los Angeles: A Pilot Feasibility Study
Lead sponsor
University of California, Los Angeles
Phase
Not applicable
Overall status
Completed
Start date
March 15, 2021
Completion date
August 31, 2021
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection, methamphetamine-dependence